Addressing the Psychosocial Impact of Vitiligo: Enhancing Patient Support and Treatment Adherence
December 9th 2024The panelist discusses how vitiligo’s psychological and social impacts significantly affect patients’ quality of life and treatment adherence, necessitating a holistic approach that addresses both physical symptoms and psychosocial support needs.
Read More
Optimizing Access in Vitiligo Treatment: Managed Care Strategies for New Therapies
December 2nd 2024Seemal Desai, M.D., FAAD, discusses how managed care organizations can improve access to advanced vitiligo treatments through updated formulary decisions and treatment algorithms while addressing insurance coverage barriers and balancing treatment aggressiveness with value-based care considerations.
Read More
Optimizing Vitiligo Treatment: Safety, Efficacy and Special Population Consideration
November 25th 2024Seemal Desai, M.D., FAAD, discusses how treatment safety and effectiveness must be carefully evaluated through monitoring clinical outcomes and patient-reported measures, with special consideration given to unique challenges in vulnerable populations like children, pregnant women and those with comorbidities, where treatment approaches require careful modification to balance efficacy and safety concerns.
Read More
Exploring Emerging Therapies in Vitiligo
November 18th 2024The panelist discusses how emerging targeted therapies like Janus kinase inhibitors and combination treatment approaches are transforming vitiligo management, with treatment selection guided by disease patterns, progression rates and individual patient response, while acknowledging the need for systematic assessment and alternative strategies for treatment-resistant cases.
Read More
Diagnostic Challenges and Treatment Impact in Vitiligo Management
November 11th 2024Seemal Desai, M.D., FAAD, discusses how immune system dysregulation and genetic variants intersect to trigger vitiligo development while highlighting diagnostic challenges including identifying disease subtypes and distinguishing vitiligo from other depigmentation disorders.
Read More